SCHEMBL2648813

SCHEMBL2648813

CCCOc1ccc(C(=O)C(=O)c2ccncc2)c(OCCC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2D6 P10635 3/20 0.48
NPC1 O15118 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
KDM4E B2RXH2 1/20 0.47
KMT2A Q03164 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
STAT3 P40763 1/20 0.44
ROCK1 Q13464 3/20 0.44
ROCK2 O75116 2/20 0.44
S1PR1 P21453 1/20 0.43
S1PR3 Q99500 1/20 0.43
DYRK3 O43781 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2648115 0.80 SMN1; SMN2 (0.46) LMNACYP3A4CYP2D6NPC1CYP2C9
SCHEMBL8218438 0.76 LMNA (0.55) LMNACYP3A4CYP2C9CYP1A2SMN1; SMN2
SCHEMBL28529318 0.76 KMT2A (0.57) LMNAKDM4EKMT2ANPSR1L3MBTL1
SCHEMBL20496442 0.76 PLK1 (0.58) LMNACYP3A4NPC1CYP1A2CYP2C19
SCHEMBL6835721 0.75 KMT2A (0.53) LMNACYP3A4CYP2D6CYP1A2KDM4E
SCHEMBL28519834 0.74 TDP1 (0.51) LMNACYP2D6CYP1A2KDM4EKMT2A
SCHEMBL20496487 0.72 LTA4H (0.51) LMNACYP3A4CYP2D6NPC1CYP1A2
SCHEMBL11322929 0.72 KMT2A (0.55) LMNAKDM4EKMT2AS1PR3L3MBTL1
SCHEMBL20496466 0.71 LMNA (0.54) LMNACYP3A4CYP2C9SMN1; SMN2KDM4E
SCHEMBL31679680 0.71 KDM4E (0.51) CYP2D6CYP1A2SMN1; SMN2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0959886-A4 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS MERCK & CO INC (US) 2001-05-02 EP disclosed
EP-0959886-A1 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS Merck & Co., Inc. (US) 1999-12-01 EP disclosed
US-5880139-A TREATING DIABETES, OBESITY, HYPERTENSION, CACHEXIA MERCK & CO., INC. (US) 1999-03-09 US disclosed
WO-1998022109-A1 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS MERCK & CO., INC. (US) 1998-05-28 WO disclosed